Assessment of Anti-RANKL Antibody in Post-menopausal Women

NCT03242512 · clinicaltrials.gov ↗
PHASE1
Phase
UNKNOWN
Status
24
Enrollment
INDUSTRY
Sponsor class

Conditions

Interventions

Sponsor

Jiangsu T-Mab Biopharma Co.,Ltd